Biotech startups in Beijing, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Phil Rivers Technology | Beijing | Series A | $29.6M | 2026-08-05 |
| QL Biopharma | Beijing | Series C | $44.7M | 2026-09-14 |
| Diyingjia Technology | Beijing | Series C | $3.0M | 2026-07-28 |
| MegaRobo | Beijing | Series C | $300.0M | 2022-06-15 |
| Avistone Pharmaceuticals | Beijing | Series B | $140.7M | 2023-12-28 |
| Darwin Cell Biology | Beijing | Series C | $27.9M | 2025-12-08 |
| NeoCura | Beijing | Series A | $78.5M | 2021-12-21 |
| Huichuang Medical | Beijing | Series B | $14.1M | 2024-05-31 |
8 rows of the CSV in 5 of its 18 columns.
- The 124 biotech startups in Beijing, China have raised $3.6B in total.
- 21 of them closed their most recent round in the last 12 months, $341.1M combined.
- The largest of those rounds is Allygen Biologics' $44.8M Series A, dated October 2026.
- IDG Capital is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 100 companies (81%).
- 21% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (41% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
6 of 124| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 | 101 to 250 | 2018 |
| Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
| Anlong Bio | Anlong Bio researches and develops nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. | Biotech | Series B | $14.3M | 2026-01-07 | $14.3M | TaiKun Fund | 51 to 100 | 2019 |
| Darwin Cell Biology | Darwin Cell Biology provides cell biotechnology services. | Biotech | Series C | $27.9M | 2025-12-08 | $62.4M | Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment | 11 to 50 | 2016 |
| MegaRobo Unicorn | MegaRobo is an AI and robotics company serving life sciences, clinical diagnosis, and applied chemistry. | Artificial intelligence | Series C | $300.0M | 2022-06-15 | Innoangel Fund, Pavilion Capital | 1,001 to 5,000 | 2016 |
Table 1. Biotech startups in Beijing, China: the 6 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 | 101 to 250 | 2018 |
| 2 | Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| 3 | Darwin Cell Biology | Darwin Cell Biology provides cell biotechnology services. | Biotech | Series C | $27.9M | 2025-12-08 | $62.4M | Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment | 11 to 50 | 2016 |
| 4 | Anlong Bio | Anlong Bio researches and develops nucleic acid drugs, including gene therapy, RNA drugs, and gene editing. | Biotech | Series B | $14.3M | 2026-01-07 | $14.3M | TaiKun Fund | 51 to 100 | 2019 |
| 5 | Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
Table 2. Biotech startups in Beijing, China: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | IDG Capital | Private equity firm | Beijing, China | 3 | 2% | 1 | Diyingjia Technology |
| 2 | Innoangel Fund | Venture capital firm | Beijing, China | 2 | 2% | ||
| 3 | Gaorong Capital | Venture capital firm | Wangjing, China | 2 | 2% | 1 | BioGeometry |
| 4 | ShengJing360 | Venture capital firm | Beijing, China | 2 | 2% | 1 | BioGeometry |
| 5 | Insight Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | Phil Rivers Technology |
| 6 | U.S.-China Green Fund | Private equity firm | Beijing, China | 1 | 1% | 1 | QL Biopharma |
| 7 | Chengdu Science and Technology Venture Capital | Venture capital firm | Chengdu, China | 1 | 1% | 1 | QL Biopharma |
| 8 | TF Capital | Venture capital firm | Pudong, China | 1 | 1% | 1 | QL Biopharma |
| 9 | Lichen Capital | Private equity firm | 1 | 1% | 1 | QL Biopharma | |
| 10 | Legend Capital | Venture capital firm | Beijing, China | 1 | 1% | 1 | Diyingjia Technology |
| 11 | Microsoft Accelerator | Startup accelerator | Beijing, China | 1 | 1% | 1 | Diyingjia Technology |
| 12 | Pavilion Capital | Private equity firm | Singapore | 1 | 1% | ||
| 13 | Primavera Capital Group | Private equity firm | Beijing, China | 1 | 1% | ||
| 14 | Bain Capital | Private equity firm | Boston, United States | 1 | 1% | ||
| 15 | Vivo Capital | Private equity firm | Palo Alto, United States | 1 | 1% |
Table 3. Biotech startups in Beijing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 100 | 81% | $3.5B |
| Software | 16 | 13% | $201.8M |
| Artificial intelligence | 14 | 11% | $154.3M |
| Hardware | 3 | 2% | $47.5M |
| Energy | 1 | 1% | $7.5M |
| Education | 1 | 1% | $2.9M |
Table 4. Biotech startups in Beijing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in Beijing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 14% | $44.8M |
| September 2026 | 1 | 5% | $44.7M |
| August 2026 | 2 | 10% | $44.5M |
| July 2026 | 4 | 19% | $49.5M |
| June 2026 | 2 | 10% | $29.5M |
| May 2026 | 1 | 5% | |
| April 2026 | 1 | 5% | |
| March 2026 | 1 | 5% | $21.8M |
| February 2026 | 1 | 5% | $14.4M |
| January 2026 | 1 | 5% | $14.3M |
| December 2025 | 4 | 19% | $77.6M |
Table 6. Biotech startups in Beijing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 17 | 14% | $263.4M |
| 2025 | 18 | 15% | $106.6M |
| 2024 | 6 | 5% | $56.1M |
| 2023 | 11 | 9% | $422.0M |
| 2022 | 19 | 15% | $849.3M |
| 2021 | 10 | 8% | $341.5M |
Table 7. Biotech startups in Beijing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 6 | 5% |
| 2020 to 2022 | 20 | 16% |
| 2015 to 2019 | 53 | 43% |
| 2010 to 2014 | 18 | 15% |
| Before 2010 | 25 | 20% |
Table 8. Biotech startups in Beijing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 4% |
| 11 to 50 | 42 | 41% |
| 51 to 100 | 21 | 20% |
| 101 to 250 | 20 | 19% |
| 251 to 500 | 7 | 7% |
| 501 to 1,000 | 4 | 4% |
| 1,001 to 5,000 | 4 | 4% |
| 5,001 to 10,000 | 1 | 1% |
Table 9. Biotech startups in Beijing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Beijing, China. On 16 November 2026 that is 124 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 6 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 124 rows: 35 have no round amount, 0 no city and 43 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Beijing, China are on the list?
- 124, in the file dated 16 November 2026. 21 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.